CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- 4 Open-market sale President and CEO sold 34,196 shares at an average $21.09 ($721,236)
- 4 Open-market sale Chief Development Officer sold 8,539 shares at an average $19.13 ($163,389)
- 4 Grant or award Chief Medical Officer acquired 12,500 shares (grant or award)
- 4 Grant or award SVP, Finance, Chief Acct Offcr acquired 15,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 33,750 shares (grant or award)
- 4 Grant or award President and CEO acquired 43,750 shares (grant or award)
- 4 Open-market sale 10% owner sold 9,925 shares at an average $20.25 ($201,026)
- 4 Open-market sale President and CEO sold 20,528 shares at $20.16 ($413,799)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Development Officer sold 988 shares at $16.81 ($16,608)
- 4 Open-market sale Chief Development Officer sold 11,444 shares at an average $16.01 ($183,271)
- 4 Open-market sale Chief Development Officer sold 9,104 shares at an average $15.14 ($137,864)
- 4 Open-market sale Chief Development Officer sold 9,666 shares at an average $15.05 ($145,453)
- 4 Open-market sale Chief Development Officer sold 1,545 shares at an average $15.01 ($23,198)
- 4 Open-market sale Chief Development Officer sold 5,887 shares at an average $15.04 ($88,565)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $13.60 ($68,004)
- 4 Open-market sale Chief Development Officer sold 400 shares at $15.22 ($6,086)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 12 · 230 filings